MINNEAPOLIS, May 31, 2024 /PRNewswire/ Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor.
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2024. Third Quarter FY2024.
MINNEAPOLIS, April 29, 2024 /PRNewswire/ Bio-Techne Corporation , a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic.